PRIMARY STUDY
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction
Key Findings: Resulting data revealed that β-caryophyllene (at 100 mg/kg) protects against neuro-inflammatory dementia.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): India
Year of Pub: 2021
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Citation: Kanojia U, et al. Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction. CNS Neurol Disord Drug Targets. 2021; 20:963-974. doi: 10.2174/1871527320666210202121103
Authors: Kanojia U, Chaturbhuj SG, Sankhe R, Das M, Surubhotla R, Krishnadas N, Gourishetti K, Nayak PG, Kishore A
